$BIIB Recent News This tiny biotech company ta
Post# of 72749
Posted On: 09/02/2014 10:40:06 AM
$BIIB Recent News
This tiny biotech company takes the real ice bucket challenge 25 min ago - Michael Brush
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Today's Market: Red Hot Biotech And Big Pharma Names To Watch 8:22 a.m. Aug. 29, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Rising Short Interest in Biotech Stocks 9:42 a.m. Aug. 27, 2014 - 247WallSt.com
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary 8:00 a.m. Aug. 27, 2014 - Zacks.com
Celgene, Gilead Lead Big Biotech Stock Movers 1:38 p.m. Aug. 26, 2014 - Investors Business Daily
Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A 8:00 a.m. Aug. 26, 2014 - CNW Group
Biogen, Celgene In Buy Range; LinkedIn Coming Back 5:43 p.m. Aug. 25, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog 5:35 p.m. Aug. 22, 2014 - Zacks.com
What Investors Gain from Large, Mid & Small-Cap Growth Funds - Mutual Fund Commentary 3:02 p.m. Aug. 20, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 1:04 p.m. Aug. 20, 2014 - TheStreet.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
6 Biotech Stocks to Buy Now With Up to 100% Upside Potential 7:41 a.m. Aug. 20, 2014 - 247WallSt.com
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog 1:20 p.m. Aug. 19, 2014 - Zacks.com
Why Biogen Idec (BIIB) Stock Is Gaining Today 11:44 a.m. Aug. 18, 2014 - TheStreet.com
UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy Approval 6:50 a.m. Aug. 18, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PTCT LGND WX BIIB 1:45 p.m. Aug. 15, 2014 - InvestorPlace.com
Today's Momo Momentum Stock Is Biogen Idec (BIIB) 9:49 a.m. Aug. 15, 2014 - TheStreet.com
Perrigo Regains Some Lost Ground On Fiscal Q4 Beat 5:36 p.m. Aug. 14, 2014 - Investors Business Daily
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Biogen Idec in Panel at the Citi 9th Annual Biotech Conference 4:02 p.m. Aug. 26, 2014 - BusinessWire - BZX
Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub 8:00 a.m. Aug. 26, 2014 - BusinessWire - BZX
Biogen Idec Names Adriana Karaboutis EVP, Technology and Business Solutions 7:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis 6:44 p.m. Aug. 15, 2014 - BusinessWire - BZX
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis 6:32 p.m. Aug. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million 8:02 a.m. Aug. 12, 2014 - BusinessWire - BZX
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023 1:00 p.m. Aug. 7, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
This tiny biotech company takes the real ice bucket challenge 25 min ago - Michael Brush
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
S&P 500 closes at record on strong earnings 4:23 p.m. July 23, 2014 - Anora Mahmudova
Apple, Intuitive power S&P 500 to record: stock market live blog recap 4:17 p.m. July 23, 2014 - blogs.marketwatch.com
Biogen rallies on earnings; Juniper slumps 10% 1:25 p.m. July 23, 2014 - Sue Chang
Biogen earnings: A lesson in how to boost an already pricey stock 10:49 a.m. July 23, 2014 - Russ Britt
Biogen Idec shares rally 12% 9:32 a.m. July 23, 2014 - Sue Chang
Biogen Idec shares up 7% in premarket trade after earnings 7:39 a.m. July 23, 2014 - Ciara Linnane
Biogen Idec's profit, sales blow past estimates 7:20 a.m. July 23, 2014 - MarketWatch.com
Biogen Idec shares rally 5.4% in premarket trade after earnings 6:53 a.m. July 23, 2014 - Tomi Kilgore
One lesson for investors from the 1990s bubble 3:13 p.m. June 19, 2014 - The Trading Deck
Tyson rallies after jumping into Hillshire chase 3:44 p.m. May 29, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Internet, biotech could spawn next Apple: Allianz CIO 7:12 a.m. April 29, 2014 - Barbara Kollmeyer
Investors gloss over Biogen earnings miss and focus on MS drug sales 2:23 p.m. April 23, 2014 - Russ Britt
Scouring the moonscape for leading stocks 3:02 p.m. April 22, 2014 - The Trading Deck
Apple, Microsoft are not the keys to this week’s news 7:00 a.m. April 22, 2014 - Marek Fuchs
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
Today's Market: Red Hot Biotech And Big Pharma Names To Watch 8:22 a.m. Aug. 29, 2014 - Seeking Alpha
Biotech Stocks 101 — What Investors Need to Know 6:59 a.m. Aug. 29, 2014 - InvestorPlace.com
Rising Short Interest in Biotech Stocks 9:42 a.m. Aug. 27, 2014 - 247WallSt.com
After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary 8:00 a.m. Aug. 27, 2014 - Zacks.com
Celgene, Gilead Lead Big Biotech Stock Movers 1:38 p.m. Aug. 26, 2014 - Investors Business Daily
Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A 8:00 a.m. Aug. 26, 2014 - CNW Group
Biogen, Celgene In Buy Range; LinkedIn Coming Back 5:43 p.m. Aug. 25, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog 5:35 p.m. Aug. 22, 2014 - Zacks.com
What Investors Gain from Large, Mid & Small-Cap Growth Funds - Mutual Fund Commentary 3:02 p.m. Aug. 20, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 1:04 p.m. Aug. 20, 2014 - TheStreet.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
6 Biotech Stocks to Buy Now With Up to 100% Upside Potential 7:41 a.m. Aug. 20, 2014 - 247WallSt.com
Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog 1:20 p.m. Aug. 19, 2014 - Zacks.com
Why Biogen Idec (BIIB) Stock Is Gaining Today 11:44 a.m. Aug. 18, 2014 - TheStreet.com
UPDATE: Morgan Stanley Reiterates On Biogen Idec Following Plegridy Approval 6:50 a.m. Aug. 18, 2014 - benzinga.com
Hottest Healthcare Stocks Now – PTCT LGND WX BIIB 1:45 p.m. Aug. 15, 2014 - InvestorPlace.com
Today's Momo Momentum Stock Is Biogen Idec (BIIB) 9:49 a.m. Aug. 15, 2014 - TheStreet.com
Perrigo Regains Some Lost Ground On Fiscal Q4 Beat 5:36 p.m. Aug. 14, 2014 - Investors Business Daily
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 4:55 p.m. Aug. 26, 2014 - PR Newswire - PRF
Biogen Idec in Panel at the Citi 9th Annual Biotech Conference 4:02 p.m. Aug. 26, 2014 - BusinessWire - BZX
Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub 8:00 a.m. Aug. 26, 2014 - BusinessWire - BZX
Biogen Idec Names Adriana Karaboutis EVP, Technology and Business Solutions 7:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis 6:44 p.m. Aug. 15, 2014 - BusinessWire - BZX
Biogen Idec’s PLEGRIDY™(Peginterferon Beta-1a) Approved in the US for the Treatment of Multiple Sclerosis 6:32 p.m. Aug. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $2M from the Advancement of ISIS-SMN Rx in Children with Spinal Muscular Atrophy 7:00 a.m. Aug. 15, 2014 - PR Newswire - PRF
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million 8:02 a.m. Aug. 12, 2014 - BusinessWire - BZX
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF
The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023 1:00 p.m. Aug. 7, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis 8:00 a.m. Aug. 5, 2014 - PR Newswire - PRF
BioMed Realty Trust To Webcast Investor Day 2014 8:00 a.m. Aug. 4, 2014 - PR Newswire - PRF
Favorable Court Ruling, Quarterly Performance Reviews, Acquisition Completion, and Contract Renewals - Research Reports on Mylan, Biogen, Medtronic, UnitedHealth and Covidien 9:20 a.m. Aug. 1, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Proteostasis Therapeutics Announces Achievement of Preclinical Milestone in Neurodegenerative Diseases Collaboration With Biogen Idec 5:30 a.m. July 30, 2014 - Marketwire
PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis 11:41 a.m. July 23, 2014 - BusinessWire - BZX
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 12:00 p.m. July 22, 2014 - PR Newswire - PRF
(0)
(0)